Welcome!

News Feed Item

Before the Bell Scans of Mylan, Forest Laboratories, Avanir Pharma, Akorn, and Medicines Co.

LONDON, March 8, 2013 /PRNewswire/ --

The U.S. Supreme Court last year upheld President Obama's Affordable Care Act (ACA). The ACA is the biggest overhaul of the healthcare industry in decades. While critics say that ACA will have a negative impact on the healthcare industry, supporters of the reform believe that the increase in the amount of insured individuals will ultimately benefit the industry. Apart from ACA, another major trend that is having an impact on drug makers such as Mylan Inc. (NASDAQ: MYL), Forest Laboratories Inc. (NYSE: FRX), Avanir Pharmaceuticals Inc. (NASDAQ: AVNR), Akorn Inc. (NASDAQ: AKRX) and The Medicines Company (NASDAQ: MDCO) is the expiration of patents on several blockbuster drugs. On Thursday, drug makers ended on a mixed note even as the broad market rallied. StockCall has taken an interest in these companies and you can now sign up to download the free technical research on MYL, FRX, AVNR, AKRX, and MDCO at

http://www.stockcall.com/registration  

Shares of Mylan Inc. slipped in trading on Thursday. However, losses were limited. The stock slipped after hitting a 52-week high of $31 in Thursday's trading session. Mylan's shares closed 0.36% lower at $30.79 on above average volume of 5.74 million. Shares of MYL have had an excellent run so far this year, gaining more than 12%, compared to a gain of more than 8.20% for the S&P 500. The drug maker company's shares have recently broken through $29 resistance level, which is a bullish signal. The stock is also trading above its 50-day and 200-day moving averages, which further confirms the bullish trend. Sign up today to read the free research report on MYL at

http://www.StockCall.com/MYL030813.pdf  

Forest Laboratories Inc.'s shares rose in Thursday's trading session; however, the gains were limited. The stock closed 0.24% higher at $37.38 on volume of 1.35 million. The company's shares are currently trading close to their 52-week high of $38.45. Year-to-date, the stock has underperformed the broad market, gaining nearly 6%, compared to a gain of more than 8.20% for the S&P 500. Forest Laboratories shares are currently trading above their 50-day and 200-day moving averages, which is a bullish signal. The bullish trend is further confirmed by the stock's MACD chart. Register to download the free technical analysis on FRX at

http://www.StockCall.com/FRX030813.pdf  

Shares of Avanir Pharmaceuticals Inc. rose more than 1% in Thursday's trading session, extending its gains for the week. The stock closed 1.01% higher at $2.99 on Thursday and has now gained more than 7.50% in the last three sessions. Year-to-date, the stock has now gained more than 14.20%. Avanir Pharma's shares have recently broken through $2.80 resistance level, which is a bullish signal. The stock has also crossed its 50-day moving average, which further confirms the bullish trend. The stock's MACD has just crossed above the signal line. Free report on AVNR can be accessed by registering at

http://www.StockCall.com/AVNR030813.pdf  

Shares of Akorn Inc. ended marginally higher in Thursday's trading session. The stock closed 0.36% higher at $13.87 on volume of 234,270. Year-to-date, the stock has gained more than 3.80%. Akorn's shares are currently facing resistance at around $14. Register with StockCall and download the research on AKRX for free at

http://www.StockCall.com/AKRX030813.pdf  

Shares of The Medicines Company fell sharply in Thursday's trading session. The stock closed 1.64% lower at $31.70 on above average volume of 797,089. Year-to-date, the stock has gained more than 32%, outperforming the broad market. Read the full free research on MDCO by signing up to StockCall at

http://www.StockCall.com/MDCO030813.pdf  

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com

SOURCE StockCall.com

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
This is going to be a live demo on a production ready CICD pipeline which automate the deployment of application onto AWS ECS and Fargate. The same pipeline will automate deployment into various environment such as Test, UAT, and Prod. The pipeline will go through various stages such as source, build, test, approval, UAT stage, Prod stage. The demo will utilize only AWS services including AWS CodeCommit, Codebuild, code pipeline, Elastic container service (ECS), ECR, and Fargate.
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, we provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading...
Poor data quality and analytics drive down business value. In fact, Gartner estimated that the average financial impact of poor data quality on organizations is $9.7 million per year. But bad data is much more than a cost center. By eroding trust in information, analytics and the business decisions based on these, it is a serious impediment to digital transformation.
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
DXWorldEXPO LLC, the producer of the world's most influential technology conferences and trade shows has announced the 22nd International CloudEXPO | DXWorldEXPO "Early Bird Registration" is now open. Register for Full Conference "Gold Pass" ▸ Here (Expo Hall ▸ Here)
@DevOpsSummit at Cloud Expo, taking place November 12-13 in New York City, NY, is co-located with 22nd international CloudEXPO | first international DXWorldEXPO and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time t...
CloudEXPO New York 2018, colocated with DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI, Machine Learning and WebRTC to one location.
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.
DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. Digital Transformation (DX) is a major focus with the introduction of DXWorldEXPO within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term.
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...